Understanding Glanzmann's Thrombasthenia (GT)

Glanzmann's Thrombasthenia (GT) is a rare genetic disorder that affects the blood's ability to clot. This condition is characterized by the malfunction of platelets, the blood cells crucial for clotting. Individuals with GT often experience abnormal and sometimes severe bleeding. If left untreated or if treatment is unsuccessful, the bleeding associated with GT can pose life-threatening risks.
A young boy with Glanzmann's Thrombasthenia standing in front of a colorful curtain.

Delving Deeper into GT

First identified in 1918, GT's impact starts to manifest in early childhood. Individuals with GT may experience severe, intermittent bleeding from the mucous membranes. In some instances, this can escalate to gastrointestinal bleeding and intracranial hemorrhage.

A little girl with Glanzmann's Thrombasthenia holding a syringe in front of a table full of supplies.

Women with GT often face unique challenges, such as heavy or prolonged menstrual bleeding (menorrhagia) and excessive bleeding during childbirth. Diagnostic blood tests for GT typically reveal an extended bleeding time and a lack of platelet aggregation.

We're Here to Help

Feeling overwhelmed? Have questions about GT? Don't hesitate to reach out to us at info@curegt.org. Our team is ready to provide the support and guidance you need.

Connect with Our Community

Join our support group and connect with others who understand your journey. Like us on Facebook and subscribe to our YouTube channel for the latest updates and resources.